These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6760210)

  • 1. Almitrine increases plasma fibrinolytic activity through the release of prostacyclin from lungs into circulation.
    Korbut R; Byrska-Danek A; Gryglewski RJ
    Pharmacol Res Commun; 1982 Nov; 14(10):959-65. PubMed ID: 6760210
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
    [No Abstract]   [Full Text] [Related]  

  • 3. The lung as a generator of prostacyclin.
    Gryglewski RJ
    Ciba Found Symp; 1980; 78():147-64. PubMed ID: 7009095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac prostacyclin release: stimulation by hypoxia and various agents.
    Kirstein A
    Scand J Haematol Suppl; 1979; 34():105-11. PubMed ID: 384504
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of almitrine bismesylate on platelet aggregation and prostacyclin biosynthesis.
    Bult H; Beetens J; Rampart M; Zonnekeyn L; Herman AG
    Eur J Respir Dis Suppl; 1983; 126():349-56. PubMed ID: 6586448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms regulating the release of deaggregating prostanoids].
    Gryglewski RJ
    Kardiol Pol; 1982; 25(10-11):801-12. PubMed ID: 6134857
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex.
    Weithmann KU
    Pharmacol Res Commun; 1982 May; 14(5):391-9. PubMed ID: 7051051
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.
    Vermylen J; Chamone DA; Verstraete M
    Lancet; 1979 Mar; 1(8115):518-20. PubMed ID: 85106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lungs as a generator of prostacyclin--hypothesis on physiological significance.
    Gryglewski RJ; Korbut R; Ocetkiewicz A; Spławiński J; Wojtaszek B; Swies J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):45-50. PubMed ID: 357998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-induced release of prostacyclin from perfused organs.
    Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1980 Apr; 12(4):339-47. PubMed ID: 6994129
    [No Abstract]   [Full Text] [Related]  

  • 11. The road to prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():11-9. PubMed ID: 2936071
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of prostacyclin by the lung.
    Splawinski J; Gryglewski RJ
    Bull Eur Physiopathol Respir; 1981; 17(4):553-69. PubMed ID: 6120018
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic metabolism of prostacyclin (PGI2) in the rabbit: formation of a potent novel inhibitor of platelet aggregation.
    Wong PY; Malik KU; Desiderio DM; McGiff JC; Sun FF
    Biochem Biophys Res Commun; 1980 Mar; 93(2):486-94. PubMed ID: 6992772
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
    Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
    Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Almitrine, a powerful liberator of prostacyclin in vivo].
    Gryglewski RJ
    Rev Fr Mal Respir; 1980; 8(6):617-20. PubMed ID: 7027373
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release.
    Weithmann KU
    Vasa; 1981; 10(3):249-52. PubMed ID: 7025499
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.
    Dembińska-Kieć A; Kostka-Trabka E; Zumda A; Byrska-Danek A; Bierón K; Grodzińska L; Kedzior A; Zelazny T
    Pharmacol Res Commun; 1982 Jun; 14(6):485-98. PubMed ID: 6750655
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of some salicylates associated with other non-steroidal anti-inflammatory drugs on the release of prostacyclin from the gastric mucosa of the rat].
    Cifone MG; Alesse E; Ianni G; Continenza MA; Conti P
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1666-71. PubMed ID: 6762887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.